OptimizeRx Corporation - Common Stock (NQ:OPRX)
Price and Volume
Detailed Quote| Volume | 603 |
| Open | 6.560 |
| Bid (Size) | 6.280 (300) |
| Ask (Size) | 6.500 (100) |
| Prev. Close | 6.560 |
| Today's Range | 6.560 - 6.560 |
| 52wk Range | 5.540 - 22.25 |
| Shares Outstanding | 17,618,607 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
February 21, 2026
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
December 17, 2025
Whetstone Sells All Freshworks Shares ↗
November 23, 2025
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript ↗
November 10, 2025
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 06, 2025
Frequently Asked Questions
Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 6.560
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 04/01/26 04:00 PM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 115.58M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 116M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.